China's medical products administrator approved Shanghai Shyndec Pharmaceutical's (SHA:600420) chemical ingredient listing for nalbuphine hydrochloride for pain relief, according to a Wednesday filing with the Shanghai Stock Exchange.

Nalbuphine hydrochloride is a central analgesic and is mainly used in its injectable form as a supplementary drug to anaesthesia, the filing said.